+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
MEDIORG

Medicamen Organics Share Price

 

 

Medicamen Organics live price: ₹22.25. It opened at ₹22 vs previous close ₹22; intraday high/low: ₹22/₹22. The 50 & 200 DMA stand at ₹23.96/₹29.13.

Medicamen Organics Performance

  • Today's Low
  • ₹22
  • Today's High
  • ₹22
  • 52 Week Low
  • ₹19
  • 52 Week High
  • ₹45
  • Open Price₹22
  • Previous Close₹22
  • Volume2,000
  • 50 DMA₹23.96
  • 100 DMA₹25.08
  • 200 DMA₹29.13

Medicamen Organics Chart

Investment Returns

  • Over 1 Month + 12.09%
  • Over 3 Month -19.68%
  • Over 6 Month -2.41%
  • Over 1 Year -46.77%

Smart Investing Starts Here Start SIP with Medicamen Organics for Steady Growth!

Invest Now

Medicamen Organics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -8.2
  • PEG Ratio
  • -
  • Market Cap Cr
  • 33
  • P/B Ratio
  • 1.1
  • Average True Range
  • 0.98
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.13
  • RSI
  • 43.7
  • MFI
  • 78.98

Medicamen Organics Financials

Medicamen Organics Technicals

EMA & SMA

Current Price
₹22.25
+ 0.05 (0.23%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹23.40
  • 50 Day
  • ₹24.00
  • 100 Day
  • ₹25.10
  • 200 Day
  • ₹29.10

Resistance and Support

22.25 Pivot Speed
  • R3 22.25
  • R2 22.25
  • R1 22.25
  • S1 22.25
  • S2 22.25
  • S3 22.25

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Medicamen Organics Ltd has an operating revenue of Rs. 86.09 Cr. on a trailing 12-month basis. An annual revenue de-growth of -41% needs improvement, Pre-tax margin of -23% needs improvement, ROE of -13% is poor and needs improvement. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 6 which is a POOR score indicating inconsistency in earnings, a RS Rating of 8 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 34 indicates it belongs to a strong industry group of Medical-Products and a Master Score of E is the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Medicamen Organics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-29 Audited Results
2026-03-13 To consider Fund Raising
2025-11-14 Quarterly Results
2025-05-29 Audited Results
2025-01-08 To consider Fund Raising

Medicamen Organics Shareholding Pattern

54.89%
0.05%
24.16%
20.9%

Medicamen Organics FAQs

Medicamen Organics share price is ₹22 As on 12 July, 2026 | 23:29

The Market Cap of Medicamen Organics is ₹33.1 Cr As on 12 July, 2026 | 23:29

The P/E ratio of Medicamen Organics is -8.2 As on 12 July, 2026 | 23:29

The PB ratio of Medicamen Organics is 1.1 As on 12 July, 2026 | 23:29

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23